HSV-1 immune escapes in microglia by down-regulating GM130 to inhibit TLR3-mediated innate immune responses

Jia Liu1,2, Xiqian Chen1,2, Junxian Liu1,2

  • 1Department of Neurology, Second Xiangya Hospital, Central South University, No. 139, Renmin Middle Road, Changsha, Hunan, China.

Virology Journal
|September 16, 2024
PubMed
Abstract

Insights

Herpes simplex virus type 1 (HSV-1) infection in microglia disrupts Golgi matrix protein 130 (GM130) and TLR3, impairing antiviral immunity. Berberine protects against HSV-1 by preserving GM130 and enhancing TLR3 immune responses.

Area of Science:

  • Neuroimmunology
  • Virology
  • Cell Biology

Background:

  • Herpes simplex virus type 1 (HSV-1) infection impacts microglia, key immune cells in the central nervous system.
  • Golgi matrix protein 130 (GM130) plays a role in cellular structure and immune signaling.
  • Toll-like receptor 3 (TLR3) is crucial for detecting viral pathogens and initiating antiviral responses.

Purpose of the Study:

  • To elucidate the mechanism by which GM130 regulates TLR3-mediated antiviral immunity during HSV-1 infection in microglia.
  • To investigate the potential immunomodulatory effects of berberine on the GM130-TLR3 pathway in HSV-1-infected microglia.

Main Methods:

  • Establishment of an in vitro model using HSV-1 infection of BV2 microglia cells.
  • Assessment of Golgi apparatus (GA) morphology, GM130 and TLR3 expression levels, and inflammatory cytokine secretion.
  • Manipulation of GM130 levels through knockdown and overexpression, and evaluation of viral titers and immune responses.

Main Results:

  • HSV-1 infection induced GA fragmentation and decreased GM130 levels, while initially increasing and then decreasing TLR3 expression.
  • GM130 knockdown exacerbated GA fragmentation, reduced TLR3 and inflammatory cytokine levels, and increased viral titers.
  • GM130 overexpression alleviated GA damage, partially restored TLR3 levels, and reduced viral loads, indicating GM130's protective role in TLR3-mediated immunity.
  • Berberine treatment protected the GA, reversed GM130 and TLR3 downregulation, and reduced HSV-1 viral titers.

Conclusions:

  • HSV-1 employs a mechanism of immune evasion in microglia by disrupting the GM130/TLR3 pathway.
  • GM130 is essential for maintaining TLR3-mediated antiviral immune responses against HSV-1.
  • Berberine demonstrates therapeutic potential by protecting the GA and enhancing TLR3-dependent antiviral immunity, offering a novel strategy against HSV-1 infection.